Clinical Trial Update: Diagnosis and Monitoring of Disease Progression Using Deep Neuro Signatures

View source ↗

Summary

Altoida is conducting a clinical trial to diagnose and monitor progression of Alzheimer's disease and mild cognitive impairment using deep neural signatures. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Altoida | Conditions: Alzheimer's Disease, Mild Cognitive Impairment | Status: ACTIVE_NOT_RECRUITING